Pan-cancer analysis reveals DDX21 as a potential biomarker for the prognosis of multiple tumor types

Pan-cancer analysis reveals DDX21 as a potential biomarker for the prognosis of multiple tumor types

BackgroundDExD-box helicase 21 (DDX21) is an essential member of the RNA helicase family. DDX21 is involved in the carcinogenesis of various malignancies, but there has been no comprehensive research on its involvement in different types of cancer.MethodThis study used TCGA, CPTAC, GTEx, GEO, FANTOM...

Full description

Bibliographic Details
Main Authors: Ankang Hu, Yonghui Wang, Jiahao Tian, Zihan Chen, Renjin Chen, Xufeng Han, Yang Chen, Tingjun Liu, Quangang Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Oncology
Subjects:
DDX21
biomarker
pan-cancer
prognosis
immune infiltration
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.947054/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.947054/full

Similar Items